AI assistant
REPLIGEN CORP — Director's Dealing 2017
Dec 18, 2017
30826_dirs_2017-12-18_91827a8f-918e-42fe-a76b-86ff2cbe0345.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2017-12-14
Reporting Person: Benjamin Howard (VP Business Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-14 | Common Stock | M | 2646 | $15.91 | Acquired | 36554 | Direct |
| 2017-12-14 | Common Stock | M | 6021 | $26.20 | Acquired | 42575 | Direct |
| 2017-12-14 | Common Stock | M | 4062 | $26.05 | Acquired | 46637 | Direct |
| 2017-12-14 | Common Stock | S | 12729 | $35.3394 | Disposed | 33908 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-12-14 | Stock Option (Right to Buy) | $15.91 | M | 2646 | Disposed | 2024-02-27 | Common Stock (2646) | Direct |
| 2017-12-14 | Stock Option (Right to Buy) | $26.20 | M | 6021 | Disposed | 2025-02-26 | Common Stock (6021) | Direct |
| 2017-12-14 | Stock Option (Right to Buy) | $26.05 | M | 4062 | Disposed | 2026-02-26 | Common Stock (4062) | Direct |
Footnotes
F1: This option is currently exercisable.
F2: $35.3394 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.22 to $35.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3: The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date.